Whitnell & Co’s MiMedx Group MDXG Stock Holding History

Whitnell & Co’s Portfolio MDXG Stock Details MDXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-500	Closed	-$4K	–	274
2013 Q4	$4K	Buy	+500	New	+$3.06K	﹤0.01%	253

Other funds holding MDXG

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

TCM

Tamarack Capital Management Carlsbad, California $840M AUM 19.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Whitnell & Co's MDXG Position: Q1 2014 in Review

Whitnell & Co sold out of MiMedx Group (MDXG) in Q1 2014, closing a stake of 500 shares — an estimated $4K sold.

Whitnell & Co first reported a position in MDXG in Q4 2013 and held it in 1 quarter. The position peaked at $4K in Q4 2013. 108 funds tracked by Wall St. Rank hold MDXG as of Q1 2014.

Whitnell & Co reported no remaining MiMedx Group position as of Q1 2014 after selling out during the quarter.
Whitnell & Co sold 500 MiMedx Group shares in Q1 2014, an estimated $4K.
Whitnell & Co first reported a position in MiMedx Group in Q4 2013 and held it in 1 quarter.
Whitnell & Co's MiMedx Group position peaked at $4K in Q4 2013.
108 funds tracked by Wall St. Rank held MiMedx Group as of Q1 2014.

Based on Whitnell & Co's 13F filing for Q1 2014, filed 5 May 2014.